ACTA1 and Hepatic fibrosis: Additionally, either of these treatments substantially inhibited profibrotic marker expression in hepatic macrophages, alleviated liver fibrosis as determined by Sirius Red staining, suppressed hepatic fibroblast activation as evaluated by α-SMA staining, and reduced the level of the collagen-specific amino acid hydroxyproline (Fig. 9a,d–f).